Nautilus Biotechnology, Inc.
NAUT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $6 | $6 | $3 | $3 |
| Gross Profit | -$6 | -$6 | -$3 | -$3 |
| % Margin | – | – | – | – |
| R&D Expenses | $50 | $47 | $36 | $27 |
| G&A Expenses | $31 | $29 | $0 | $0 |
| SG&A Expenses | $31 | $29 | $24 | $21 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$6 | -$6 | $0 | $0 |
| Operating Expenses | $75 | $70 | $60 | $48 |
| Operating Income | -$81 | -$76 | -$64 | -$50 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $11 | $12 | $6 | $0 |
| Pre-Tax Income | -$71 | -$64 | -$58 | -$50 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$71 | -$64 | -$58 | -$50 |
| % Margin | – | – | – | – |
| EPS | -0.56 | -0.51 | -0.46 | -0.6 |
| % Growth | -9.8% | -10.9% | 23.3% | – |
| EPS Diluted | -0.56 | -0.51 | -0.46 | -0.6 |
| Weighted Avg Shares Out | 125 | 125 | 125 | 84 |
| Weighted Avg Shares Out Dil | 125 | 125 | 125 | 84 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $13 | $6 | $0 |
| Interest Expense | $0 | $0 | $6 | $0 |
| Depreciation & Amortization | $6 | $2 | $3 | $3 |
| EBITDA | -$64 | -$74 | -$55 | -$47 |
| % Margin | – | – | – | – |